首页> Lung cancer (Amsterdam, Netherlands)> Decoding circulating tumor DNA to identify durable benefit from immunotherapy in lung cancer.

Decoding circulating tumor DNA to identify durable benefit from immunotherapy in lung cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hylke C,Donker

第一单位： Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, the Netherlands. Electronic address: h.c.donker@umcg.nl.

作者： Hylke C,Donker ^[1] ; Ed,Schuuring ^[2] ; Ellen,Heitzer ^[3] ; Harry J M,Groen ^[4]

作者单位： Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, the Netherlands. Electronic address: h.c.donker@umcg.nl. ^[1] Department of Pathology, University of Groningen and University Medical Center Groningen, the Netherlands. Electronic address: e.schuuring@umcg.nl. ^[2] Institute of Human Genetics, Diagnostic & Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria; Christian Doppler Laboratory for Liquid Biopsies for Early Detection of Cancer, Medical University of Graz, Graz, Austria. Electronic address: ellen.heitzer@medunigraz.at. ^[3] Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, the Netherlands. ^[4]

关键词 Circulating tumor DNA Immunotherapy Liquid biopsy Non-small cell lung cancer

医学主题词癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing);人类(Humans);免疫疗法(Immunotherapy);肺肿瘤(Lung Neoplasms);突变(Mutation)

DOI 10.1016/j.lungcan.2022.05.013

PMID 35716631

发布时间 2022-08-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交